AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

Clinical trial NCT06219941 · RECRUITING

Trial details

NCT number: NCT06219941
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Gastric Cancer Gastroesophageal Junction Cancer Biliary Tract Cancer Pancreatic Ductal Adenocarcinoma

Start date: 2023-12-13
Primary completion: 2026-11-17
Enrollment: 226

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.